Asthma Spacers Market Analysis and Forecast to 2032: By Type (Aerochamber, Optichamber, Volumatic, InspirEase), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Optical Stores, Online Pharmacies), and Region
The Asthma Spacers market was valued at over USD 1.6 billion in 2021 and it is anticipated to grow further to USD 3.1 billion by 2031, at a CAGR of 6.4% during the forecast period.
Both children and adults can get asthma, which is a chronic condition. Asthma results from a restricted airway in the lungs caused by inflammation and tight muscles around the airways. The typical symptoms of asthma include wheezing, chest tightness, coughing, and shortness of breath. A holding chamber in the form of a tube is an asthma spacer. Less medication enters the mouth and throat thanks to the spacers’ help getting it straight to the lungs. The metered-dose inhaler, often known as a puffer, is very helpful while utilizing the asthma spacer (MDI). The appropriate administration of aerosolized medication is aided by a spacer.
Global Asthma Spacer Market Scope and Report Structure
| Report Attribute | Details |
|---|---|
| Market Size in 2021 | US$ 1.6 Billion |
| Market Size in 2031 | US$ 3.1 Billion |
| CAGR % | 6.4% |
| Historic Period | 2015-2020 |
| Forecast Period | 2022-2031 |
| Base Year | 2021 |
| Segments Covered | Type, Distribution Channel, and Region |
| Key Companies | Cipla Inc., PARI GmbH, Koninklijke Philips N.V., GSK plc., HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, AGPMED Rossmax International Ltd., and Teleflex among others. |
| Regional Scope | North America, Europe, Asia Pacific, Central & South America, Middle East & Africa |
| Analysis Coverage | Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments |
Market Trends and Drivers
The rising prevalence of respiratory disorders, which is a major element fueling the expansion of the worldwide asthma spacer market, is the cause of the rising demand for asthma spacer. An increased chance of having asthma is associated with a number of variables, including allergic diseases including eczema and rhinitis (hay fever), urbanization, exposure to tobacco smoke, and viral respiratory infections. For instance, the World Health Organization (WHO) estimates that in 2019 asthma killed over 461,000 people and impacted nearly 262 million people. Furthermore, according to Asthma U.K., there were 77,124 hospital admissions for asthma in 2017 and someone in the U.K. gets a potentially fatal asthma episode every 10 seconds.
Market Restraints and Challenges
The development of the global market for asthma spacers during the forecast period would be significantly hampered by alternative treatments for asthma. Bronchial thermoplasty is an effective treatment for asthma. It is a tried-and-true alternative asthma treatment. For instance, the Alair BT System study, which included patients treated with it, reported encouraging results in May 2017 from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2) study, according to Boston Scientific, a manufacturer of medical devices. The research results demonstrated that BT decreased problems in adult patients with severe chronic asthma.
Global Asthma Spacers Market Segmental Overview
The report analyses the global asthma spacers market based on the type, distribution channel, and region.
Global Asthma Spacers Market by Type
Based on the type, it is segmented into aerochamber, optichamber, Volumatic, and inspirease. The Aerochamber segment is anticipated to dominate the market during the forecast period. The increasing level of air pollution leads to respiratory diseases, which is anticipated to drive the global asthma spacer market growth during the forecast period.
Global Asthma Spacers Market by Distribution Channel
Based on the distribution channel, it is segmented into hospital pharmacies, retail pharmacies, optical stores, and online pharmacies. The hospital pharmacies segment is anticipated to dominate the market during the forecast period. The growing prevalence of asthma across the globe is boosting the growth of the market.
Geographical Analysis of the Global Asthma Spacers Market
Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. Due to factors including the easy accessibility of technologically improved products, the rising prevalence of asthma, and increased healthcare spending in the region, North America is predicted to lead the market. One of the major factors influencing the expansion of the studied market in North America is the increased incidence of asthma, particularly among the senior population in the United States.
Major Players in the Global Asthma Spacers Market
The major players studied in the report are Cipla Inc., PARI GmbH, Koninklijke Philips N.V., GSK plc., HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, AGPMED Rossmax International Ltd., and Teleflex among others.
COVID-19 Impact
The most recent epidemic was the coronavirus (COVID-19) pandemic, which was first identified on December 31, 2019, in Wuhan, China. On March 11, 2020, the World Health Organization classified COVID-19 as a pandemic. Worldwide reports of coronavirus (COVID-19) infections and deaths reached approximately 225 million cases and 4.63 million, respectively, as of September 14, 2021, according to the World Health Organization’s Coronavirus Disease (COVID-19) Weekly Epidemiological Update. The financial standing of companies across all industries has been harmed by the coronavirus (COVID-19) outbreak and lockdown in numerous nations throughout the world. One industry that has been severely damaged by the pandemic is the private healthcare sector. The private healthcare industry is now financially burdened as a result of the lockdown in several nations.
Recent Developments
- June 2021, Lupin Limited, a renowned pharma company announced its UK subsidiary. The organization got an endorsement from the Medications and Medical services items Administrative Office to showcase Luforbec 100/6 µg compressed metered portion inhaler.
- July 2020, AstraZeneca and Honeywell are collaborating on the creation of next-generation respiratory inhalers using propellent HFO-1234ze, which has up to 99.9% less Global Warming Potential than propellants currently used in respiratory treatment.
- April 2019, Cipla announced the launch of Niveoli. The product is India’s first beclomethasone-formoterol combination hydrofluoroalkane inhaler for adults indicated against asthma and COPD.
- February 2018, Teva Pharmaceuticals announced the launch of QVAR RediHaler for treatment of asthma patients.
Frequently Asked Questions
Q1. How big is the Asthma Spacers market?
Ans. The global Asthma Spacers market size was USD 1637.5 million in 2021 and it is anticipated to grow further till USD 3036.7 million by 2031, at a CAGR of 6.4% from 2022 to 2031.
Q2. What is the Asthma Spacers market growth rate?
Ans. The growth rate of the Asthma Spacers market is 6.4%.
Q3. Which region holds a major market share for the Asthma Spacers market?
Ans. North America holds a major market share of the Asthma Spacers market in 2021.
Q4. Which segment accounted for the largest Asthma Spacers market share?
Ans. By distribution channel, the hospital pharmacies segment accounted for the largest Asthma Spacers market share.
Q5. Who are the key players in the Asthma Spacers market?
Ans. The global Asthma Spacers market report includes players such as Cipla Inc., PARI GmbH, Koninklijke Philips N.V., GSK plc., HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, AGPMED Rossmax International Ltd., and Teleflex among others.
Q6. What are the factors driving the Asthma Spacers market growth?
Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Asthma Spacers market players?
Ans. The key growth strategies of Asthma Spacers market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Asthma Spacers market during the forecast period?
Ans. The Asia-Pacific region will provide more business opportunities for the Asthma Spacers market during the forecast period.
Table of Contents
Chapter 1. Asthma Spacers Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Type
3.3. Market Attractiveness Analysis, by Distribution Channel
Chapter 4. Asthma Spacers Market Outlook
4.1. Asthma Spacers Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Product Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Asthma Spacers Market
4.7. Impact of the Russia and Ukraine War on the Asthma Spacers Market
Chapter 5. Asthma Spacers Market, by Type
5.1. Market Overview
5.2. Aerochamber
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Optichamber
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.4. Volumatic
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.5. InspirEase
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 6. Asthma Spacers Market, by Distribution Channel
6.1. Market Overview
6.2. Hospital Pharmacies
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Retail Pharmacies
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.4. Optical Stores
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.5. Online Pharmacies
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
Chapter 7. Asthma Spacers Market, by Region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. North America Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.3. North America Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.2.4. North America Asthma Spacers Market Size and Forecast by Country, 2021-2031, ($Million)
7.2.5. The U.S.
7.2.5.1. The U.S. Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.5.2. The U.S. Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.2.6. Canada
7.2.6.1. Canada Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.6.2. Canada Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.2.7. Mexico
7.2.7.1. Mexico Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.2.7.2. Mexico Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3. Europe
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Europe Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.3. Europe Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.4. Europe Asthma Spacers Market Size and Forecast by Country, 2021-2031, ($Million)
7.3.5. Germany
7.3.5.1. Germany Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.5.2. Germany Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.6. France
7.3.6.1. France Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.6.2. France Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.7. U.K.
7.3.7.1. U.K. Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.7.2. U.K. Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.8. Spain
7.3.8.1. Spain Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.8.2. Spain Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.9. Italy
7.3.9.1. Italy Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.9.2. Italy Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.3.10. Rest of Europe
7.3.10.1. Rest of Europe Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.3.10.2. Rest of Europe Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Asia-Pacific Asthma Spacers Market Size and Forecast by Country, 2021-2031, ($Million)
7.4.3. Asia-Pacific Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.4. Asia-Pacific Asthma Spacers Market Size and Forecast by Product, 2021-2031, ($Million)
7.4.5. China
7.4.5.1. China Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.5.2. China Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.4.6. India
7.4.6.1. India Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.6.2. India Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.4.7. Japan
7.4.7.1. Japan Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.7.2. Japan Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.4.8. South Korea
7.4.8.1. South Korea Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.8.2. South Korea Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.4.9. Rest of APAC
7.4.9.1. Rest of APAC Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.4.9.2. Rest of APAC Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Rest of the World Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.3. Rest of the World Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.5.4. Rest of the World Asthma Spacers Market Size and Forecast by Country, 2021-2031, ($Million)
7.5.5. Latin America
7.5.5.1. Latin America Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.5.2. Latin America Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.5.6. Middle East
7.5.6.1. Middle East Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.6.2. Middle East Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
7.5.7. Africa
7.5.7.1. Africa Asthma Spacers Market Size and Forecast by Type, 2021-2031, ($Million)
7.5.7.2. Africa Asthma Spacers Market Size and Forecast by Distribution Channel, 2021-2031, ($Million)
Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Vendor Benchmarking
8.4. Developmental Strategy Benchmarking
8.4.1. New Product Development
8.4.2. Product Launches
8.4.3. Business Expansions
8.4.4. Partnerships, Joint Ventures, and Collaborations
8.4.5. Mergers and Acquisitions
Chapter 9. Company Profiles
9.1. Cipla Inc.
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. PARI GmbH
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Koninklijke Philips N.V.
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. GSK plc.
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. HAAG-STREIT GROUP
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. Laboratoire ProtecSom
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. Monaghan Medical Corporation
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Koo Medical Equipment
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. AGPMED Rossmax International Ltd.
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. Teleflex
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report
Key Players
Global Asthma Spacer Market Segmentation
By Type
- Aerochamber
- Optichamber
- Volumatic
- InspirEase
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Optical Stores
- Online Pharmacies
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The UK
- Germany
- France
- Spain
- Rest of Europe
- The Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa